Effect of dsRNA on Mesangial Cell Synthesis of Plasminogen Activator Inhibitor Type 1 and Tissue Plasminogen Activator by Wörnle, Markus et al.
Fax +41 61 306 12 34
E-Mail karger@karger.ch
www.karger.com
 Original Paper 
 Nephron Exp Nephrol 2009;113:e57–e65 
 DOI: 10.1159/000228409 
 Effect of dsRNA on Mesangial Cell Synthesis
of Plasminogen Activator Inhibitor Type 1 and 
Tissue Plasminogen Activator 
 Markus Wörnle a    Maximilian Roeder a    Matthias Sauter a    Monika Merkle b    
Andrea Ribeiro a 
 a  Medical Policlinic, Ludwig Maximilians University,  Munich , and  b  Department of Nephrology, Klinikum Traunstein, 
 Traunstein , Germany 
viral receptors TLR3 and RIG-I upregulates the expression of 
PAI-1 and t-PA. Knockdown of viral receptors with specific 
siRNA abolishes the induction of PAI-1 and t-PA.  Conclusion: 
For the first time a link between the activation of viral recep-
tors on MC and potentially causative agents in the develop-
ment of glomerulosclerosis and tubulointerstitial fibrosis is 
shown. The progression of inflammatory processes to glo-
merulosclerosis can be postulated to be directly enhanced 
by viral infection.  Copyright © 2009 S. Karger AG, Basel 
 Introduction 
 Tissue plasminogen activator (t-PA) and plasminogen 
activator inhibitor type 1 (PAI-1) are the major regulators 
of plasmin generation. t-PA plays a pivotal role in the fi-
brinolytic system by converting the proenzyme plasmin-
ogen into the active enzyme plasmin. Plasmin is a potent 
broad-spectrum protease that cleaves fibrin and is able to 
degrade several components of the extracellular matrix 
(ECM) by activating procollagenases and matrix metal-
loproteinases (MMPs)  [1] . PAI-1 is an important inhibitor 
of plasminogen activators  [2] .
 In proliferative or crescentic forms of glomerulone-
phritis, the extent of fibrin deposits correlates with the 
severity of glomerular lesions  [3, 4] . Progression to renal 
failure is mainly attributed to the development of glo-
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 Abstract 
 Background/Aims: Viral infections are a major problem 
worldwide and many of them are complicated by virally in-
duced glomerulonephritides. Progression of kidney disease 
to renal failure is mainly attributed to the development of 
renal fibrosis characterized by the accumulation of extracel-
lular matrix components in the mesangial cell compartment 
and the glomerular basement membrane. Plasminogen ac-
tivator inhibitor type 1 (PAI-1) and tissue plasminogen acti-
vator (t-PA) are major regulators of plasmin generation and 
play an important role in generation and degradation of 
 glomerular extracellular matrix components. Viral receptors 
expressed by mesangial cells (MC) are known to be key me-
diators in immune-mediated glomerulonephritis. We inves-
tigated the effect of stimulation of the viral receptors toll-
like receptor 3 (TLR3) and retinoic acid-inducible gene I 
(RIG-I) on the expression of PAI-1 and t-PA.  Methods: Expres-
sion of PAI-1 and t-PA in immortalized human MC stimulated 
with polyriboinosinic:polyribocytidylic acid [poly(I:C)] RNA 
and cytokines were analyzed by real-time RT-PCR and ELISA. 
 Results: Incubation of MC with poly(I:C) RNA to activate the 
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merular and interstitial fibrosis  [5] with glomeruloscle-
rosis being characterized by an accumulation of ECM  [6, 
7] . As plasmin activates MMPs and thereby degrades 
ECM components, a reduced glomerular plasmin pro-
duction caused by decreased t-PA or increased PAI-1 ac-
tivity was postulated to be relevant for the progression of 
human glomerulonephritis and various forms of experi-
mental glomerulonephritis in several studies  [8–11] .
 With viral infections gaining in global importance, 
the number of virally induced glomerulonephritides in-
creases steadily. During the course of hepatitis C virus 
(HCV) infection, immune complexes and viral RNA are 
found in the mesangium and often cause clinically rele-
vant glomerulonephritis  [12, 13] . HIV-associated ne-
phropathy affects up to 10% of HIV-seropositive indi-
viduals and is mainly characterized by focal segmental 
glomerulosclerosis  [14] . IgA nephropathy as the most 
common glomerulonephritis is often preceded by viral 
upper respiratory tract infections and is characterized by 
mesangial cell proliferation and mesangial matrix ex-
pansion  [15] . 
 Toll-like receptors (TLRs) are an essential part of the 
innate immune system and are expressed on immune 
cells as well as on a number of non-immune cells. TLRs 
recognize conserved pathogen-associated molecular pat-
terns associated with microbial pathogens and induce an 
immune response  [16] . Eleven members of the TLR fam-
ily (TLR1–11) have so far been identified in mice and ten 
in humans, each recognizing a distinct component of an 
infectious agent  [17] . TLR3 recognizes dsRNA of viral 
origin as exemplified by polyriboinosinic:polyribocyti-
dylic acid [poly(I:C)] RNA, a synthetic analogue of viral 
dsRNA  [18, 19] . TLR3 expression is not restricted to leu-
kocytes but also occurs in non-immune organs, includ-
ing lung and bowel  [20] . Beside TLR3, the helicase reti-
noic acid-inducible gene I (RIG-I) may also act as a sensor 
of viral infections through recognition of viral dsRNA 
and may upregulate type I interferons  [21] .
 In adult healthy kidneys, TLR3 can be found on me-
sangial cells (MC), vascular smooth muscle cells and col-
lecting duct epithelium by immunohistochemistry. Im-
mortalized human MC have low TLR3 mRNA levels with 
a predominant intracellular protein localization. We have 
shown that TLR3 expression in MC is increased by tumor 
necrosis   factor-  (TNF-  ), interleukin (IL)-1  , interfer-
on-  (IFN-  ) and   the TLR3 ligand poly(I:C) RNA, which 
also increases mRNA and protein synthesis of IL-6, IL-
1  , M-CSF, IL-8/CXCL8, RANTES/CCL5, MCP-1/CCL2 
and ICAM-I in MC and has antiproliferative and pro-
apoptotic effects. We therefore postulated that TLR3 may 
be important for   the clearance of any viral RNA reaching 
the glomerular mesangium. In highly replicative viral in-
fections such as active hepatitis C, free viral RNA as well 
as viral RNA bound to immune complexes could trigger 
glomerular inflammatory processes and result in glo-
merulonephritis by activating TLR3  [13, 22] . In support 
of this hypothesis, we have previously shown the role of 
TLR3 expressed on human MC in hepatitis C-associated 
glomerulonephritis  [23] . We found increased mRNA lev-
els for TLR3 and for proinflammatory cytokines and che-
mokines in microdissected glomeruli from biopsies of 
hepatitis C-associated but not idiopathic membranopro-
liferative glomerulonephritis. We also have previously 
shown that activation of viral receptors leads to an up-
regulation of mesangial expression of MMP9 without af-
fecting synthesis of MMP2 and the tissue inhibitor of 
MMPs TIMP-1  [24] .
 We now investigated the effect of viral RNA on mes-
angial synthesis of PAI-1 and t-PA as important regula-
tors of glomerular fibrin turnover and potentially caus-
ative agents in development of glomerular sclerosis and 
tubulointerstitial fibrosis. Stimulation of immortalized 
human MC with poly(I:C) RNA mimicking viral RNA 
was done and expression of PAI-1 and t-PA analyzed. 
Specific mediation of the effects by viral receptors was 
shown by knockdown experiments.
 Methods 
 Cell Culture of Human MC 
 Immortalized human MC were grown as described previous-
ly  [25] . MC were incubated with TNF-  (25 ng/ml), IL-1  (10 ng/
ml) and IFN-  (20 ng/ml) or culture medium alone (control) for 
24 h, washed with PBS, incubated in culture medium (containing 
10% fetal calf serum) for 6 h and washed again with PBS. Subse-
quently, MC were incubated with culture   medium containing 
poly(I:C) RNA in different concentrations as indicated below or 
culture medium alone (control). For expression analysis, extrac-
tion of total RNA was performed using   an RNeasy Mini Kit (Qia-
gen, Germany) with DNase digestion.
 Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) 
Analysis 
 RT-PCR analysis was done as   described  [26] . For RT-PCR, 2   g 
of isolated total RNA underwent   random primed reverse tran-
scription using a modified Moloney murine leukemia virus re-
verse transcriptase (Superscript; Life Technologies, Germany). In 
parallel, 2-  g aliquots   were processed without reverse transcrip-
tion to control for contaminating genomic DNA. Real-time RT-
PCR was performed on a TaqMan ABI 7700 sequence detection 
system (PE Applied Biosystems, Germany). GAPDH was used as 
reference housekeeping gene. All water controls were negative for 
target and housekeeper. RT-PCR quantitation was done by the 
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Pfaffl method. Sequences with the following GenBank accession 
numbers were used to design the predeveloped TaqMan assay re-
agents (PDAR) primers and probe, purchased from Applied Bio-
systems: NM003265/U88879 (human TLR3), NM014314 (human 
RIG-I), NM000602.1, M16006.1, M14083.1, X12701.1 (human 
PAI-1), NM033011.2, NM000930.3, M15518.1, D01096.1 (human 
t-PA) and M33197 (human GAPDH).
 Knockdown of Gene Expression with Short Interfering RNA 
(siRNA) 
 Predesigned siRNA specific for TLR3 and RIG-I were pur-
chased from Ambion (Japan). Transfection of siRNA into the cells 
was performed as described before  [27] . Scrambled siRNA was 
used as the non-specific negative control of siRNA (Ambion).
 Statistical Analysis 
 Values are provided as mean  8 SEM. Statistical analysis was 
performed by ANOVA analysis. Significant differences are indi-
cated for p values  ! 0.05 ( * ) or 0.01 ( * * ), respectively.
 Results 
 mRNA Expression of PAI-1 and t-PA by Human MC 
 MC were cultured under standard conditions or stimu-
lated with the cytokines TNF-  , IL-1  and IFN-  alone or 
in combination or with poly(I:C) RNA (5   g/ml), a syn-
thetic analogue of viral RNA, for 24 h. Expression of PAI-
1 and t-PA was analyzed by real-time RT-PCR. PAI-1 ex-
pression was not affected by IFN-  stimulation and not 
significantly increased by TNF-  or IL-1  alone. PAI-1 ex-
pression was increased significantly and to a comparable 
extent by combined stimulation with TNF-  , IL-1  and  
IFN-   and  by  poly(I:C)  RNA.  Basal  expression of  t-PA was 
not affected by any of the proinflammatory  cytokines in-
dividually or in combination. In contrast, poly(I:C) RNA 
increased mesangial t-PA expression ( fig. 1 ).
 Effect of Incubation with Poly(I:C) RNA on Expression 
and Synthesis of PAI-1 and t-PA 
 MC exhibit a basal expression of viral receptors TLR3 
and RIG-I which is increased under inflammatory condi-
tions comparable to those occurring in immune-medi-
ated glomerular disease  [23] . mRNA expression of TLR3 
and RIG-I was analyzed by RT-PCR under basal condi-
tions and after a 24-hour stimulation with a combination 
of proinflammatory cytokines (TNF-  , IL-1  , IFN-  ). 
The low basal expression of TLR3 and RIG-I was in-
creased when cells were stimulated with the proinflam-
matory cytokines ( fig. 2 a, b). To test the relevance of ac-
tivation of viral receptors TLR3 and RIG-I for PAI-1 and 
t-PA synthesis, MC were stimulated with poly(I:C) RNA 
mimicking viral RNA. MC were incubated with (Comb) 
or without (Basal) a combination of cytokines for 24 h, 
washed with PBS, incubated in culture medium for 6 h 
and washed again with PBS. Subsequently, MC were in-
cubated with culture medium alone (control) or culture 
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 Fig. 1. Expression of PAI-1 and t-PA by human MC. Human MC 
were cultured under standard conditions (Basal) or after stimula-
tion with proinflammatory cytokines TNF-  , IL-1  and IFN-  
alone or in combination (Comb) as well as the analogue of viral 
RNA poly(I:C) RNA (5   g/ml) for 24 h before RNA extraction. 
Real-time RT-PCR was performed using primers specific for hu-
man PAI-1 and t-PA as indicated in Methods.  a Basal expression 
of PAI was not affected by stimulation with IFN-  . TNF-  and 
IL-1  stimulation led to an increase of PAI-1 synthesis. The cyto-
kine combination (TNF-  , IL-1  , IFN-  ) and poly(I:C) RNA 
clearly increased PAI-1 expression.  b Basal expression of t-PA was 
not affected by any of the cytokines individually or in combina-
tion. Poly(I:C) RNA increased t-PA synthesis. Results are mean  8 
SEM of three independently performed experiments and rRNA 
served as the reference gene. Significant differences are indicated 
for p values  ! 0.05 ( * ). 
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medium containing poly(I:C) RNA in different concen-
trations (0.5, 5, 10   g/ml) for 24 h. PAI-1 ( fig. 2 c, d) and 
t-PA ( fig. 2 e, f) expression and synthesis were analyzed by 
RT-PCR and ELISA. A dose-dependent increase in PAI-1 
mRNA was observed after stimulation of the cells with 
poly(I:C) RNA both under basal conditions and after cy-
tokine pretreatment. The cytokine pretreatment had no 
additive effect on the induction of PAI-1 expression. Pro-
tein analysis by ELISA showed a dose-dependent increase 
in PAI-1 release with poly(I:C) RNA stimulation; protein 
synthesis was enhanced by pretreatment with cytokines. 
Exposure of MC to poly(I:C) RNA at a concentration of 
0.5 or 5   g/ml increased significantly t-PA mRNA levels 
in a dose-dependent manner, an effect which was further 
0.00E+00
a
TL
R3
 v
s.
 rR
N
A
4.00E–04
8.00E–04
1.20E–03
1.60E–03
2.00E–03
Comb
*
Basal
0.00E+00
c
PA
I-
1 
vs
. r
RN
A
1.00E–01
2.00E–01
3.00E–01
4.00E–01
5.00E–01
*6.00E–01
7.00E–01
8.00E–01
9.00E–01
1.00E+00
C
on
tr
ol
Po
ly
(I:
C
)
RN
A
0.
5 
μ
g
/m
l
Po
ly
(I:
C
)
RN
A
5 
μ
g
/m
l
Po
ly
(I:
C
)
RN
A
10
 μ
g
/m
l
*
*
*
*
0.00E+00
e
t-
PA
 v
s.
 rR
N
A
5.00E–02
1.00E–01
1.50E–01
2.00E–01
2.50E–01 *
3.00E–01
3.50E–01
4.00E–01
4.50E–01
5.00E–01
C
on
tr
ol
Po
ly
(I:
C
)
RN
A
0.
5 
μ
g
/m
l
Po
ly
(I:
C
)
RN
A
5 
μ
g
/m
l
Po
ly
(I:
C
)
RN
A
10
 μ
g
/m
l
*
*
*
*
*
0
d
PA
I-
1 
(n
g
/m
l)
20
40
60
80
100
*120
140
160
180
200
C
on
tr
ol
Po
ly
(I:
C
)
RN
A
0.
5 
μ
g
/m
l
Po
ly
(I:
C
)
RN
A
5 
μ
g
/m
l
Po
ly
(I:
C
)
RN
A
10
 μ
g
/m
l
*
*
*
*
*
f
0
t-
PA
 (n
g
/m
l)
2
4
6
8
10
*
12
14
16
C
on
tr
ol
Po
ly
(I:
C
)
RN
A
0.
5 
μ
g
/m
l
Po
ly
(I:
C
)
RN
A
5 
μ
g
/m
l
Po
ly
(I:
C
)
RN
A
10
 μ
g
/m
l
*
*
0.00E+00
b
RI
G
-I
 v
s.
 rR
N
A
4.00E–05
8.00E–05
1.20E–04
1.60E–04
Comb
*
Basal
Comb
Basal
 PAI-1 and t-PA in Glomerulonephritis Nephron Exp Nephrol 2009;113:e57–e65 e61
enhanced with pretreatment of MC with the cytokine 
combination. A significant increase in t-PA protein was 
observed only when cells were pretreated with the com-
bination of proinflammatory cytokines and additionally 
stimulated with poly(I:C) RNA.
 Time Course of PAI-1 and t-PA Expression and 
Synthesis after Stimulation with Poly(I:C) RNA 
 Expression and synthesis of PAI-1 and t-PA were ana-
lyzed by real-time RT-PCR and ELISA after incubation of 
MC with poly(I:C) RNA (5   g/ml) for up to 24 h with and 
without pretreatment of cells with the cytokine combina-
tion specified above. Stimulation both with the cytokines 
and with poly(I:C) RNA led to a comparable increase in 
PAI-1 mRNA, which started to be significant compared 
to baseline after 6 h. The increase in PAI-1 mRNA after 
poly(I:C) RNA stimulation was enhanced significantly 
when MC were pretreated with the cytokine combina-
tion. Under these conditions, PAI-1 expression peaked at 
3 and 6 h. At 12 and 24 h, PAI-1 expression was found to 
be increased compared to MC cultured under basal con-
ditions, but no difference was found to cells stimulated 
with cytokines alone ( fig. 3 a). Analysis by ELISA showed 
a significant increase in PAI-1 synthesis only in cytokine 
pretreated cells after poly(I:C) stimulation for 12 and 
24 h. The effect of poly(I:C) RNA stimulation alone on 
PAI-1 synthesis was comparable to treatment with the 
 cytokine combination; the induced increase in PAI-1 
synthesis was significant compared to basal conditions 
only at 24 h ( fig. 3 b). t-PA mRNA expression was in-
creased in a time-dependent manner by poly(I:C) RNA 
stimulation and further enhanced after additional cyto-
kine pretreatment. When MC were prestimulated with 
proinflammatory cytokines, the increase in t-PA mRNA 
was significant at 6, 12 and 24 h, the maximal peak was 
found after 24 h. Again there was no difference between 
the significant increases in t-PA mRNA induced by cyto-
kines and with poly(I:C) RNA alone at 12 and 24 h ( fig. 3 c). 
No increase in t-PA synthesis was observed by ELISA 
when cells were stimulated with poly(I:C) RNA for 3 and 
6 h, both with and without cytokine pretreatment. After 
12 and 24 h of poly(I:C) RNA stimulation, t-PA release 
increased significantly under basal conditions, an effect 
which was further enhanced when cells were pretreated 
with the cytokine combination. The maximum increase 
was observed at 24 h ( fig. 3 d).
 Effect of Transfection with siRNA Specific for TLR3 
and RIG-I on Poly(I:C) RNA-Induced PAI-1 and t-PA 
Expression and Synthesis 
 MC constitutively express mRNA for TLR3 and RIG-I. 
Transfection of MC with siRNA specific for these viral 
receptors for 24 h caused remarkable downregulation of 
these genes under basal conditions. Expression of TLR3 
after transfection with siRNA specific for TLR3 was 10% 
of basal TLR3 expression, expression of RIG-I after trans-
fection with siRNA specific for RIG-I was 17% of bas -
al RIG-I expression ( fig. 4 a). MC were stimulated with 
poly(I:C) RNA (5   g/ml) for 24 h. To avoid influence of 
cytokines on expression of PAI-1 and t-PA, cells were not 
pretreated with the cytokine combination mentioned 
above. Poly(I:C) RNA significantly increased expression 
of PAI-1 ( fig. 4 b) and t-PA ( fig. 4 c). siRNA specific for 
TLR3 reduced significantly poly(I:C) RNA-induced ex-
pression of PAI-1 and t-PA. siRNA specific for RIG-I had 
no effect on poly(I:C) RNA-induced expression of PAI-1 
and t-PA.
 Discussion 
 In this study we analyzed the expression and synthesis 
of PAI-1 and t-PA in human MC in response to viral RNA 
exemplified by the synthetic analogue of viral RNA 
poly(I:C) RNA.
 Fig. 2. Effect of incubation with poly(I:C) RNA on production of 
PAI-1 and t-PA. MC exhibit a low expression of TLR3 ( a ) and RIG-
I ( b ) under basal conditions (Basal) which could be increased by 
a 24-hour stimulation with a combination of the proinflamma-
tory cytokines TNF-  , IL-1  and IFN-  (Comb). To test the effect 
of activation of viral receptors MC were preincubated with (Comb) 
or without (Basal) a combination of proinflammatory cytokines 
(TNF-  , IL-1  , IFN-  ) for 24 h, washed with PBS, incubated in 
culture medium for 6 h, washed again with PBS and incubated 
with or without (control) poly(I:C) RNA in different concentra-
tions (0.5, 5, 10   g/ml) for 24 h before RNA extraction. Expression 
for PAI-1 and t-PA were analyzed by real-time RT-PCR ( c ,  e ) and 
ELISA ( d ,  f ). Expression of PAI-1 ( c ,  d ) was increased by poly(I:C) 
RNA in a dose-dependent manner in a range from 0.5 to 10   g/ml 
poly(I:C) RNA under basal conditions and after additional cyto-
kine pretreatment. Stimulation with poly(I:C) RNA ( e ,  f ) in-
creased t-PA expression of MC in a concentration-dependent 
manner in a range from 0.5 to 10   g/ml poly(I:C) RNA, an effect  
 enhanced by pretreatment with the cytokine combination, when 
mRNA expression was analyzed by RT-PCR. When t-PA release 
was analyzed by ELISA, the dose-dependent increase was signifi-
cant, when cells were pretreated with the combination of proin-
flammatory cytokines. Results are mean  8 SEM of three inde-
pendently performed experiments and rRNA served as the refer-
ence gene. Significant differences are indicated for p values  ! 0.05 
( * ). 
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 Glomerulonephritides are characterized by inflam-
matory processes leading to the release of a variety of pro-
inflammatory cytokines and growth factors. Progression 
to renal failure in glomerular disease is mainly attributed 
to the development of glomerulosclerosis and interstitial 
fibrosis. The turnover of ECM components is a tightly 
controlled process with the plasminogen-plasmin system 
playing a major role in the dissolution of fibrin and the 
degradation of ECM proteins by activation of MMPs  [2] . 
As a matter of fact, an increased PAI-1 expression was 
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 Fig. 3. Time-dependent influence of poly(I:C) RNA on synthesis 
of PAI-1 and t-PA. MC were pretreated under basal (Basal: open 
symbols) or cytokine combination conditions (Comb: filled sym-
bols) as described in Methods and after washing they were incu-
bated with (diamonds, discontinued line) or without (squares, 
continuous line) poly(I:C) RNA (5   g/ml) for different time inter-
vals (3, 6, 12 or 24 h). The expressions of PAI-1 and t-PA were de-
termined by real-time RT-PCR ( a ,  c ) and ELISA ( b ,  d ). Incubation 
of MC with poly(I:C) RNA increased PAI-1 mRNA expression 
when MC were cultivated under standard conditions and stimu-
lated with poly(I:C) RNA with a maximum increase at 12 h. When 
cells were pretreated with proinflammatory cytokines and incu-
bated with poly(I:C) RNA, an early increase of PAI-1 synthesis was 
observed at 3 and 6 h. Increase was significant at 12 and 24 h com-
pared to untreated cells, but no difference was seen compared to 
cytokine stimulated cells without poly(I:C) RNA incubation. PAI-
1 release measured by ELISA showed no significant difference af-
ter 3 and 6 h poly(I:C) RNA stimulation. After 12 h, PAI-1 release 
increased significantly when cells were stimulated with poly(I:C) 
RNA and pretreated with the combination of proinflammatory 
cytokines. After 24 h, PAI-1 synthesis was significantly increased 
when the cells were stimulated with poly(I:C) RNA under basal 
conditions, an effect which was further enhanced when cells were 
additionally pretreated with the cytokine combination. Poly(I:C) 
RNA stimulation results in a time-dependent increase of t-PA syn-
thesis with a maximum at 24 h, an effect   enhanced by pretreat-
ment with the cytokine combination. Values are means  8 SEM of 
three independently performed series of experiments. rRNA 
served as the reference gene. Significant differences are indicated 
for p values   ! 0.05 ( * ). Poly(I:C) RNA-stimulated conditions were 
compared with unstimulated conditions, both with and without 
additional cytokine pretreatment, respectively. 
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found in several forms of glomerulonephritis  [9] . Glo-
merular PAI-1 can originate from infiltrating inflamma-
tory cells or resident mesangial and endothelial cells. A 
common mechanism is supposed to regulate PAI-1 in all 
these cells, as previously supposed in murine models of 
lupus nephritis  [28] .
 During the course of virally induced glomerulone-
phritides, immune complexes as well as free viral RNA 
reach the mesangium  [12, 13] . In adult healthy kidneys 
the viral receptor TLR3 is expressed on MC and is sup-
posed to be important for the clearance of viral RNA. We 
have previously shown a role for TLR3 in HCV-associ-
ated glomerulonephritis  [23] . Furthermore, activation of 
viral receptors as experimentally exemplified by stimula-
tion with poly(I:C) RNA is supposed to be involved in the 
induction of various forms of glomerulonephritis as even 
lupus nephritis is found to worsen in MRL-Fas(lpr) mice 
injected with poly(I:C) RNA  [29] . MC in cell culture have 
low TLR3 mRNA levels with a predominant intracellular 
protein localization. TLR3 expression is increased by 
TNF-  , IL-1  , IFN-  , the combination of these cytokines 
and   the TLR3 ligand poly(I:C) RNA. Viral dsRNA has 
been recognized as a major ligand for TLR3 in many cell 
types including dendritic cells and non-immune cells 
such  as  MC   [23,  30] .  It  has   been   recently   shown   that  
also single-stranded RNA can act as a ligand for TLR3. 
Poly(I:C) RNA is a synthetic analogue for viral RNA and 
activates TLR3  [31] . In addition to TLR3, a role for the 
helicase RIG-I in viral infections was shown for several 
cell types  [21, 26] .
 In our study, human immortalized MC express PAI-1 
under basal culture conditions. PAI-1 expression was in-
duced by treatment with poly(I:C) RNA, by stimulation 
with TNF-  and IL-1  alone and by combined stimula-
tion with the proinflammatory cytokines TNF-  , IL-1  
and IFN-  . The induction of PAI-1 by poly(I:C) RNA 
treatment was time- and dose-dependent and was en-
hanced after 3 and 6 h of poly(I:C) stimulation by pre-
treatment of MC with cytokines. This might be explained 
by an immediate upregulation of TLR3 by cytokine stim-
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 Fig. 4. Effects of transfection with siRNA for TLR3 and RIG-I on 
poly(I:C) RNA-induced expression of PAI-1 and t-PA. To test the 
effectivity of siRNA on basal gene suppression ( a ), expression of 
TLR3 and RIG-I was analyzed with (+ siRNA) and without (Bas-
al) a 24-hour transfection with the specific siRNAs by real-time 
RT-PCR. siRNA specific for TLR3 and RIG-I suppressed the bas-
al expression of the respective genes significantly. MC were stim-
ulated with poly(I:C) RNA (5   g/ml) for 24 h. siRNA specific for 
TLR3 clearly reduced poly(I:C) RNA-induced mRNA expression 
of PAI-1 ( b ) and t-PA ( c ). siRNA specific for RIG-I had no effect 
on poly(I:C) RNA-induced expression of PAI-1 and t-PA. Values 
are means  8 SEM of three independently performed series of 
 experiments. rRNA served as the reference gene. Significant dif-
ferences are indicated for p values  ! 0.05 ( * ) or 0.01 ( * * ), respec-
tively. 
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ulation  [23] or a facilitated signal transduction. In con-
trast, the expression of t-PA in MC was not significantly 
affected by stimulation with any of the cytokines either 
individually or in combination, but was increased sig-
nificantly by poly(I:C) RNA, especially in cytokine pre-
treated cells. Data from ELISA substantiate a correspond-
ing increase in PAI-1 and t-PA protein synthesis with a 
delay of 6–12 h. Knockdown experiments with TLR3-
specific siRNA confirm the specificity of TLR3 activa-
tion and signal transduction in PAI-1 regulation as the 
poly(I:C) RNA-mediated increase in expression of PAI-1 
and t-PA was inhibited by siRNA specific for TLR3 but 
not for RIG-I.
 It therefore has to be supposed that the stimulation of 
viral receptors as TLR3 in the glomerular mesangium 
leads to an upregulation of both PAI-1 and t-PA, with the 
PAI-1 increase being earlier and more pronounced, espe-
cially under inflammatory conditions. This might result 
in an imbalance in plasmin activation and a reduced dis-
solution of fibrin and turnover of ECM proteins with 
generation of glomerular fibrosis. The observation that 
activation of TLR3 increases expression of both PAI-1 
and t-PA is consistent with in vitro findings in several 
forms of glomerulonephritis  [32] ; it can be explained by 
the fact that physiologically both profibrotic and profi-
brinolytic components are necessary for regeneration 
and healing in glomerular inflammatory processes. The 
development of matrix abnormalities might not be spe-
cific for virally induced glomerular injury but is sup-
posed to be characteristic for any form of immune-medi-
ated glomerular disease. The functional role of mesangial 
viral receptors in the regulation of mesangial ECM is 
supported by our previous finding of an upregulation of 
MMP 9 in MC after activation of TLR3; the expression of 
MMP 2 and the MMP inhibitor TIMP-1 was not affected 
and RIG-I did not influence MMP expression  [24] . Our 
results were obtained from an immortalized human 
 mesangial cell line and similar experiments will therefore 
need to be undertaken using primary human MC in the 
future to determine whether they exhibit similar re-
sponses.
 In summary, our results demonstrate how activation 
of viral receptors by dsRNA influences the mesangial 
synthesis of PAI-1 and t-PA. These results suggest that 
viral RNA could also influence the process of generation 
and degradation of ECM in the mesangium during im-
mune-mediated glomerulonephritis by affecting mesan-
gial PAI-1 and t-PA synthesis. We consider this to be a 
novel and attractive hypothesis for the development of 
glomerulosclerosis in virally induced glomerulonephrit-
ides.
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